# MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma

> **NCT04596930** · NA · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 15 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **PROCEDURE:** Laser ablation thermal therapy

## Key facts

- **NCT ID:** NCT04596930
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-22
- **Primary completion:** 2022-02-11
- **Final completion:** 2022-05-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04596930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04596930, "MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04596930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*